Anika Therapeutics Inc
Ownership
Ownership Structure
Who owns Anika Therapeutics Inc (ANIK)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 84.3% of the shares are freely tradable; institutional investors hold 94.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 11.92 | 1,594,893 | -3.6 | 03/31/2026 |
| Caligan Partners LP | 10.72 | 1,435,130 | +0.0 | 06/30/2026 |
| Morgan Stanley - Brokerage Accounts | 6.52 | 872,066 | +12.9 | 03/31/2026 |
| Acadian Asset Management LLC | 4.53 | 606,544 | +35,143.7 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.53 | 605,777 | +0.0 | 03/31/2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 3.96 | 529,503 | -0.9 | 03/31/2026 |
| Renaissance Technologies Corp | 3.75 | 502,217 | -2.6 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 3.37 | 451,095 | -1.7 | 06/30/2026 |
| Capital Management Corp | 3.35 | 448,474 | +0.2 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.97 | 397,824 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Fischetti Gary P | Director | 54,015 | 1,134,315 $ | Aug 4, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Fischetti Gary P | Director | Buy | 1,000 | 20.32 | 20,315 |
| Aug 3, 2026 | Fischetti Gary P | Director | Buy | 1,000 | 20.75 | 20,745 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.